**Recent IPO activity in 2026 has been robust, led by AI-related issuers and large technology transactions.** Through early November, U.S. offerings have raised well over $100 billion year-to-date, highlighted by SpaceX’s record $75 billion June listing and subsequent deals such as SK hynix. Multiple smaller and mid-sized IPOs priced in late October, including Aspen Neuroscience and Bambusa Therapeutics, while Anthropic’s S-1 filing on October 26 points to a potential multi-billion-dollar Nasdaq debut targeted for mid-November. Market conditions remain supportive amid elevated equity valuations and investor appetite for growth names, though volatility in AI shares and upcoming elections introduce short-term caution. Additional S-1 filings and scheduled pricings through December keep the pipeline active, with trader consensus reflecting high implied probability of further listings before year-end.